SCND Q1 Revenue Jumps 30%, Net Loss Narrows; Cash Runway Secured for a Year
summarizeSummary
Scientific Industries Inc. reported first-quarter 2026 results, showing a 30.2% year-over-year revenue increase to $1.23 million and an improved net loss of $1.59 million, leading to a reduced diluted EPS loss of $0.13. This positive development follows the company's previous 10-K filing which included a going concern warning. The current report highlights operational improvements, including new higher-margin products and cost-cutting measures, and crucially, projects that cash and investments will fund operations for at least one year. For a micro-cap company, these improvements in revenue growth, reduced losses, and a secured cash runway are material, suggesting a stabilization of financial health and potentially alleviating immediate liquidity concerns. Traders will watch for sustained revenue growth and continued progress towards profitability in future reports.
At the time of this announcement, SCND was trading at $0.75 on OTC in the Life Sciences sector, with a market capitalization of approximately $8.9M. The 52-week trading range was $0.30 to $2.25. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.